Jeffery Goad, PharmD, MPH

Personalizing risk, offering a platform alternative, and timing the appointment around a patient's weekend can turn a hesitant conversation into a completed COVID-19 vaccination.

mRNA and protein-based COVID-19 vaccines reach the same immune target through different biological routes, a distinction pharmacists can use to guide product selection for patients.

With ACIP sidelined and no functioning quorum, this season's COVID-19 vaccine guidance has fragmented, leaving pharmacists to navigate unpredictable coverage, stocking, and counseling questions.

COVID-19 has faded from headlines, but Dr. Marcel Curlin explains the virus still claims tens of thousands of American lives each year, concentrated among older and immunocompromised patients.

Jeffery Goad, PharmD, MPH, president of the National Foundation for Infectious Diseases, provided his expert perspectives on the ongoing hantavirus outbreak.

With the federal government continuing its reconsideration of vaccine guidelines in the US, Jeff Goad, PharmD, MPH, explains what it means for community pharmacies.

Jeff Goad, PharmD, MPH, joins Drug Topics to discuss potential COVID-19 vaccine removal and what it could mean for the future of mRNA vaccine technology.

Jeff Goad, PharmD, MPH, president of the NFID, discusses the nuances behind COVID-19 vaccine updates and what it can mean for patients and pharmacies alike.

An expert discusses how pharmacists are transforming from passive dispensers to active public health care members by proactively identifying and recommending vaccines to patients.

An expert discusses how pharmacists must balance patient demand with high logistical costs and risks when stocking specialized travel vaccines (eg, yellow fever) due to high acquisition cost.

An expert discusses how pharmacists can implement formal referral pathways to a specialized center that transfers the completed vaccination record back to the originating pharmacy profile.

An expert discusses how community pharmacists must establish clear guidelines for managing travel vaccine requests and triaging patients based on itinerary complexity and vaccine availability.

Panelists discuss how streamlining complex administrative burdens ensures efficient revenue cycles, thereby expanding professional services into high-value areas, such as specialty travel health.

An expert discusses how, by leveraging the high accessibility of community pharmacies, pharmacists can administer vaccines and combat patient hesitancy using active listening and motivational interviewing.

Understanding post-PREP implications is critical for evaluating current public health delivery, identifying ongoing access, and informing future policy.

During Viral Hepatitis Awareness Month, Jeff Goad, PharmD, MPH, joined Over the Counter to discuss hepatitis vaccines and the common trends pharmacists in this space should keep in mind.

President of the National Foundation for Infectious Diseases, Jeff Goad, PharmD, MPH, discusses how pharmacists can help improve hepatitis A and B vaccine rates across the country.

Jeff Goad, PharmD, MPH, discusses hesitancy for hepatitis vaccines and the necessary advice pharmacists can utilize to help patients manage these misconceptions.

Jeff Goad, PharmD, MPH, discusses hepatitis viruses and the current vaccination schedules available for patients to stay protected.

Pharmacists play a critical role in public education, and the potential for expanding clinical services is evident.

Jeffery Goad, PharmD, MPH, president of the National Foundation for Infectious Diseases, reflects on the COVID-19 pandemic 5 years later.

Pharmacists are resilient, community-focused professionals who played a pivotal role in navigating the unprecedented challenges of the COVID-19 pandemic.